Management beyond Insulin in Gestational Diabetes Mellitus: A Review Update

Authors

  • Sharmin Jahan Assistant Professor, Department of Endocrinology, Bangbabandhu Sheikh Mujib Medical University, Dhaka
  • MA Hasanat Professor, Department of Endocrinology, Bangbabandhu Sheikh Mujib Medical University, Dhaka

DOI:

https://doi.org/10.3329/jninb.v4i2.38931

Keywords:

Gestational Diabetes, MNT, Oral anti-diabetic drugs, Insulin

Abstract

Hyperglycemia is the most common endocrine disorder of pregnancy. As compared to Diabetes in pregnancy(DIP) the management of gestational DM(GDM) has always been a topic of controversy. Medical nutrition therapy(MNT) is the cornerstone of GDM management. 80-90% of GDM mothers can be treated by MNT alone and the rest will require drugs. Considerable controversy surrounds the use of oral anti-diabetic medications in pregnancy. The most widely studied drugs are glyburide and metformin. Conflicting results have been produced by different studies. However recent meta-analyses have shown that they can be an attractive alternative to insulin if long term safety data become available. Till then it might be too early to make a final comment on their use in GDM.

Journal of National Institute of Neurosciences Bangladesh, 2018;4(2): 145-149

Downloads

Download data is not yet available.
Abstract
504
PDF
565

Downloads

Published

2018-12-10

How to Cite

Jahan, S., & Hasanat, M. (2018). Management beyond Insulin in Gestational Diabetes Mellitus: A Review Update. Journal of National Institute of Neurosciences Bangladesh, 4(2), 145–149. https://doi.org/10.3329/jninb.v4i2.38931

Issue

Vol. 4 No. 2 (2018)

Section

Review Articles

License

Copyright on any research article in the Journal of National Institute of Neurosciences Bangladesh is retained by the author(s).

The authors grant the National Institute of Neurosciences Bangladesh a license to publish the article and identify itself as the original publisher.

Articles in the Journal of National Institute of Neurosciences Bangladesh are Open Access articles published under the Creative Commons CC BY-NC License (https://creativecommons.org/licenses/by-nc/4.0/)

This license permits use, distribution and reproduction in any medium, provided the original work is properly cited, and it is not used for commercial purposes.